Pharming Group N.V. reported earnings results for the first quarter ended March 16, 2023. For the first quarter, the company reported sales was USD 42.54 million compared to USD 46.62 million a year ago. Net loss was USD 12.21 million compared to net income of USD 3.46 million a year ago.

Basic loss per share from continuing operations was USD 0.019 compared to basic earnings per share from continuing operations of USD 0.005 a year ago. Diluted loss per share from continuing operations was USD 0.017 compared to diluted earnings per share from continuing operations of USD 0.005 a year ago.